Calprotectin for Evaluation of Acute Infection and Sepsis and Prognosis Characterization in the Emergency Department

• Conditions: A41; A49; Other sepsis; Bacterial infection of unspecified site

• Registration Number: DRKS00020521
• Lead Sponsor: Emergency Department Campus Benjamin Franklin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-13
• Study Completion: 2022-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 403

Inclusion Criteria

Adult patients presenting or admitted to the emergency department with clinical signs of acute infection, as determined by the attending physician.

Exclusion Criteria

Age <18 years

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Predictive power (positive and negative predictive power) of Calprotectin in relation to the presence of a bacterial, viral or no infection.

Secondary Outcome Measures

Name	Time	Method
Predictive power (positive and negative predictive power) of Calprotectin in relation to: <br>- 30 day mortality <br>- requiring intensive care within 72hrs of admission <br>- manifestation of organ failure <br>- indicated antibiotic therapy